Fidelity Investments’s Zymergen Inc. Common Stock ZY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-1,121
Closed -$3K 5690
2022
Q3
$3K Sell
1,121
-240
-18% -$583 ﹤0.01% 4511
2022
Q2
$2K Sell
1,361
-113
-8% -$189 ﹤0.01% 4649
2022
Q1
$4K Sell
1,474
-837,451
-100% -$3.56M ﹤0.01% 4535
2021
Q4
$5.61M Buy
838,925
+106,142
+14% +$1.03M ﹤0.01% 2333
2021
Q3
$9.65M Buy
732,783
+656,493
+861% +$13.9M ﹤0.01% 2141
2021
Q2
$3.05M Buy
+76,290
New +$3.01M ﹤0.01% 2452

Fidelity Investments's ZY Position: Q4 2022 in Review

Fidelity Investments sold out of Zymergen Inc. Common Stock (ZY) in Q4 2022, closing a stake of 1,121 shares — an estimated $3K sold.

Fidelity Investments first reported a position in ZY in Q2 2021 and held it in 6 quarters. The position peaked at $9.65M in Q3 2021. 0 funds tracked by Wall St. Rank hold ZY as of Q4 2022.

  • Fidelity Investments reported no remaining Zymergen Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Fidelity Investments sold 1,121 Zymergen Inc. Common Stock shares in Q4 2022, an estimated $3K.
  • Fidelity Investments first reported a position in Zymergen Inc. Common Stock in Q2 2021 and held it in 6 quarters.
  • Fidelity Investments's Zymergen Inc. Common Stock position peaked at $9.65M in Q3 2021.
  • 0 funds tracked by Wall St. Rank held Zymergen Inc. Common Stock as of Q4 2022.

Based on Fidelity Investments's 13F filing for Q4 2022, filed 13 Feb 2023.